New Transcriptomic Biomarkers of 5-Fluorouracil Resistance

The overall response rate to fluoropyrimidine monotherapy in colorectal cancer (CRC) is limited. Transcriptomic datasets of CRC patients treated with 5-fluorouracil (5FU) could assist in the identification of clinically useful biomarkers. In this research, we aimed to analyze transcriptomic cohorts...

Descripción completa

Detalles Bibliográficos
Autores principales: Fekete, János Tibor, Győrffy, Balázs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867124/
https://www.ncbi.nlm.nih.gov/pubmed/36675023
http://dx.doi.org/10.3390/ijms24021508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867124/
https://www.ncbi.nlm.nih.gov/pubmed/36675023
http://dx.doi.org/10.3390/ijms24021508

Ejemplares similares